Podcasts about amcp

Industry Organizations and Associations with AMCP On this episode host Tom Testa continues his series on industry organizations that are making a difference for their members with Susan Cantrell, CEO of the Academy of Managed Care Pharmacy (AMCP). With a diverse membership and history dating back to 1988, AMCP strives to ensure patient access to affordable medication and shape healthcare policy. Take a listen and learn more about AMCP. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”.

Pediatric Narcolepsy Challenges, Opportunities, and Emerging Therapies On this episode host Amy Lugo, PharmD, BCPS, BC-ADM, FAPhA, FAMCP, Founder and CEO of LoneStar Health Solutions, is joined by Dr. Joshua Lennon, Assistant Professor at the University of Tennessee Health Science Center, to discuss the unique challenges of diagnosing and treating narcolepsy in children. They explore why pediatric narcolepsy is frequently misdiagnosed, the significant delays many patients experience before receiving an accurate diagnosis, and the impact untreated symptoms can have on learning, social development, and long-term health. The conversation also examines current FDA-approved treatment options, promising advances in orexin-targeted therapies, and the important role managed care professionals play in improving timely access to evidence-based care for children living with narcolepsy.

Navigating Treatment, Access, and Outcomes in Idiopathic Hypersomnia On this episode guest host Denise Wolff, PharmD, CEO & Founder of Denise & Co., LLC, welcomes Zachary Contreras, PharmD, RPh, Director of Pharmacy Benefits, Sharp Health Plan, for a discussion on idiopathic hypersomnia (IH), a chronic neurological sleep disorder that remains widely underrecognized despite its profound impact on patients' lives. Together, they explore the challenges of diagnosing IH, including a diagnostic delay that can exceed a decade, the significant burden the condition places on work, relationships, education, and overall quality of life, and the reasons many patients remain invisible within healthcare systems. The episode highlights practical steps health plans can take today to reduce barriers to care, improve long-term outcomes, and help patients with idiopathic hypersomnia receive the diagnosis and treatment they need sooner. Sponsored by Jazz Pharmaceuticals.

How Targeted Therapies Are Reshaping Treatment for Platinum-Resistant Ovarian Cancer Platinum-resistant ovarian cancer remains one of the most challenging settings in oncology, with limited treatment options and historically poor outcomes for many patients. On this episode of Unscripted, the AMCP Podcast, guest host Abby Kim, PharmD, BCOP, Senior Director of Clinical Strategy and Oncology Specialty Solutions at Prime Therapeutics, sits down with Kathleen Moore, MD, Deputy Director of the Fred & Pamela Buffett Cancer Center and Professor of Obstetrics and Gynecology at Nebraska Medicine, to discuss the evolving treatment landscape for recurrent ovarian cancer and the growing role of biomarker-driven care. Dr. Moore explores the history and challenges of treating platinum-resistant disease, reviews the clinical evidence behind ELAHERE®, examines the importance of folate receptor alpha testing, and shares insights on treatment sequencing, patient-reported outcomes, safety and tolerability considerations, and emerging therapies that may further expand options for patients and inform decision-making across managed care. Sponsored by Abbvie, Inc. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Awakening the Future: How Emerging Narcolepsy Type 1 Therapies Are Redefining Care and Expectations On this episode guest host Steve Kheloussi, PharmD, MBA, FAMCP, principal consultant at Kheloussi Consulting, speaks with Amy Lugo, PharmD, BCPS, BC-ADM, FAPhA, FAMCP, founder and CEO of LoneStar Health Solutions, about the evolving treatment landscape for narcolepsy. The discussion explores the burden of delayed diagnosis, the real-world impact of excessive daytime sleepiness and cataplexy, and how treatment may shift from symptom management toward addressing the underlying disease process. Steve and Amy also examine formulary considerations, patient-reported outcomes, utilization management challenges, and how managed care organizations can balance access, value, and patient-centered care as new therapies enter the market. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Payer & Provider Dynamics: Addressing Non-Medical Switching in Oncology for CLL/SLL On this episode guest host Ryan Haumschild, PharmD, MS, MBA, CPEL, Vice President of Pharmacy at Emory University and Emory Health Plan, Winship Cancer Institute, discusses the real-world impact of non-medical switching in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) with Timothy Mok, Manager of Clinical Utilization Intelligence at Kaiser Permanente and board-certified oncology pharmacist, focusing on the drivers behind switching, the risks of disrupting effective therapy, and how shared decision-making and dose modification can help maintain adherence and improve patient outcomes. Sponsored by Abbvie. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Defining Clinical Utility in Managed Care On this episode guest host Steve Kheloussi, Principal Consultant with Kheloussi Consulting, sits down with Dr. John Fox, Senior Medical Director for the Americas at Illumina, to untangle the complexities of clinical utility. Drawing on his experience as a pediatrician and former health plan medical director, Dr. Fox explains why defining clinical utility remains a challenge for the industry and explores its critical role in precision medicine. From ending the "diagnostic odyssey" in pediatric rare diseases to the life-saving impact of large-panel biomarker testing in oncology, they discuss how the true value of a test lies in its power to change patient management and improve net health outcomes. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode guest host Steve Kheloussi, PharmD, MBA, FAMCP speaks with Ria Westergaard, Head of Commercial Strategy Intelligence Solutions at Evernorth Health Services, and Rekha Lakshmanan, Executive Director of The Immunization Partnership, about the growing tension between science, policy, and public perception. From misinformation and social media to access gaps and real-world data, they unpack what's really shaping vaccination decisions today—and where managed care can help rebuild trust and improve outcomes. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

MS Looks Like Me: Diagnosis Delays, Disparities, and the Real Cost of Being Misdiagnosed On this episode guest host Steve Kheloussi, PharmD, MBA, FAMCP, speaks with Blair and Dallas Burleson about delayed MS diagnosis, the realities of living with an unpredictable disease, and the impact on caregivers. The conversation also examines where managed care can better support patients, through more flexible, individualized access to treatment and a clearer understanding of real-world patient needs. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Recorded live in Nashville at AMCP Annual 2026, our latest Pharmacy Friends shares takeaways on how real-world medical and pharmacy data, pharmacist-led outreach, and benefit integration are shaping payer decision-making. 00:45 - Why real-time evidence matters09:37 - High-touch pharmacist-to-prescriber outreach helps deliver hard-dollar savings.23:51 – Rare disease insight and reinforcing the need for individualized management and payer case-management opportunities.36:02 -- Why site of care in CAR-T and BiTE therapy matter43:20 – Why mental health parity compliance in government programs matter now 52:55-- Integration signal by highlighting the value of coordinated care.These insights are foundational to how Prime delivers value to health care payers. Using evidence-driven expertise on how therapies are used, where gaps exist and which patients benefit most from additional support, Prime translates research into smarter clinical strategies and high-touch support for patients.  Dive into the real stories, smart insights, and everyday moments that bring the world of pharmacy and everyday life together—one authentic conversation at a time.

On this episode Kirollos Hanna, PharmD, Director of Pharmacy at Minnesota Oncology, discusses the rapidly shifting treatment landscape for chronic lymphocytic leukemia (CLL). The discussion covers the transition toward oral fixed-duration frontline regimens, the latest 2026 NCCN guidelines, and the emerging role of MRD testing. They also explore the clinical and economic implications of these therapies, including how the Inflation Reduction Act (IRA) is reshaping Medicare formulary strategies and patient access. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

HER2-Positive Biliary Tract Cancer: Biomarkers, Targeted Therapy, and Managed Care Access On this episode, Jeffrey Dunn, PharmD, MBA, President and CEO of Cooperative Benefits Group, discusses the rapidly evolving treatment landscape for HER2-positive biliary tract cancer (BTC) and its implications for managed care. The discussion covers the importance of biomarker testing and molecular profiling in guiding targeted therapy, key NCCN guideline considerations across lines of treatment, and the clinical and economic impact of timely access to HER2-directed therapies. We also discuss payer-provider collaboration strategies to improve testing, coverage alignment, and patient access in this rare and aggressive form of cancer. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode host Fred Goldstein invites Angela Luong, PharmD, Senior Clinical Consultant at Pharmaceutical Strategies Group in this last installment of our rare disease series. Our discussion focuses on the burden of sickle cell disease, chronic pain management, limited treatment options, and the implications for managed care programs, including the use of data and care coordination to improve patient outcomes. This activity is supported by an independent medical education grant from Agios Pharmaceuticals, Inc. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit: The Power of Partnership: Bridging Patients and Payers in Sickle Cell Disease Management. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode host Fred Goldstein invites Janna Evans, Director of Pharmacy Sales Support at Blue Cross and Blue Shield of Texas, as they continue their rare disease series with a focus on hemophilia and the substantial clinical, financial, and psychosocial burdens it places on patients and families. We discuss how health plans manage high-cost therapies, balance individualized patient needs with access requirements, and navigate prior authorization and step-therapy processes. Janna also highlights the need for better patient-reported outcomes, the day-to-day impact of the disease, and the broader considerations for employers and caregivers within managed care. This activity is supported by an independent medical education grant from Genentech Inc., and Pfizer Inc. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit: ⁠The Power of Partnership: Bridging Patients and Payers in Hemophilia Management. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode Fred Goldstein invites Ami Gopalan, Senior Vice President of Strategic Content and Growth Optimization at Precision AQ in a continion of AMCP's rare disease series with an in-depth look at IgA nephropathy (IgAN), a progressive autoimmune kidney disease that often goes undiagnosed until advanced stages. As a patient living with IgAN, Ami brings both a professional and personal perspective to the discussion as we explore the disease's silent progression, the burden it places on patients and families, the evolving treatment landscape, and how managed care can better incorporate patient value, clinical guidelines, and emerging evidence to support long-term outcomes. This podcast is supported by an independent medical education grant from Alexion and AstraZeneca Rare Disease. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit: The Power of Partnership: Bridging Patients and Payers in IgA Nephropathy Management. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On this episode Fred Goldstein invites Steve Kheloussi, PharmD, MBA, FAMCP, Principal Consultant at Kheloussi Consulting, LLC, in the first installment of our four-part series on rare diseases. We discuss a practical overview of Duchenne muscular dystrophy (DMD), the current treatment landscape, and the evidence gaps that complicate payer decision-making. We also touch on the importance of what patients and caregivers need to maintain function, reduce fatigue, and navigate the significant emotional and practical burdens of care. This podcast is supported by an independent medical education grant from ITF Therapeutics. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit:  ⁠The Power of Partnership: Bridging Patients and Payers in Duchenne Muscular Dystrophy Management⁠. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On this episode Fred Goldstein invites Dr. Iltefat Hamzavi, MD, FADD to explore vitiligo as a complex autoimmune disease with significant psychosocial and clinical implications. They discuss the burden of delayed diagnosis, the societal and emotional challenges patients face, and the importance of early, individualized treatment. He outlines current therapeutic approaches—including topical agents, phototherapy, systemic options, and surgical interventions—and highlights the condition's associations with other autoimmune diseases. The conversation underscores how education, support, and emerging medical advances are reshaping outcomes and quality of life for people living with vitiligo. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode Fred Goldstein invites Sheena Crosby, PharmD, BCGP, Inflammatory Bowel Disease Clinical Pharmacist at the Mayo Clinic in Florida. Sheena breaks down the American College of Gastroenterology's (ACG) updated guidelines for ulcerative colitis and Crohn's disease, highlighting major shifts in treatment strategy, including the move toward earlier use of advanced therapies and updated goals focused on symptom control, mucosal healing, and sustained remission. She also outlines the critical payer considerations emphasized in the guidelines—from eliminating unnecessary step-therapy requirements to ensuring timely access to induction and maintenance therapy—changes that have direct implications for patient outcomes and health-system performance. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode Fred Goldstein invites Marty Acevedo, MS, RD, Patient Advocate and President & Board Chair of the Parkinson's Association of San Diego. Marty shares her personal journey with Parkinson's disease—from a delayed diagnosis to managing symptoms, treatment decisions, and the impact on daily life. She discusses the importance of individualized care, the essential role of caregivers, and the value of evidence-based resources. Marty also highlights her involvement in the Michael J. Fox Foundation's Parkinson's Progression Markers Initiative (PPMI) research study and offers perspective on emerging advances and potential disease-modifying therapies that may shape the future of Parkinson's care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode, host Fred Goldstein invites Dr. Kartik Kalra, Clinical Nephrologist at Geisinger Medical Center. We discuss IgA nephropathy and the newly released, comprehensive 2025 KDIGO guidelines. We explore what IgAN is, why diagnosis is often delayed, how it commonly presents, and the impact the disease can have over a patient's lifetime. Dr. Kalra also discusses what prompted the latest guideline revision, how thinking around IgAN has evolved, and what these changes signal for clinicians, health systems, and the managed care community. This podcast is supported by an independent medical education grant from Calliditas Therapeutics. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please use the instructions provided here: ⁠AMCP Learn - claim CPE instructions https://amcplearn.org/sites/default/files/media/2024-10/AMCP%20Learn%20-%20Claim%20CPE%20Instructions_0.pdf Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode, host Fred Goldstein invites Daryl Pritchard, Senior Vice President of Science Policy at the Personalized Medicine Coalition. They discuss how precision medicine is transforming care and where critical gaps remain. Daryl shares findings from recent studies showing how many patients are still lost along the testing-to-treatment pathway, even in well-established areas like lung cancer, and explains what's needed to bridge those gaps. The conversation highlights the role of payers, providers, and policymakers in aligning science, practice, and policy to deliver truly individualized care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On this episode, host Fred Goldstein invites Franck Rahaghi, MD, MHS, Executive Director of Cardiopulmonary Global Medical Affairs at United Therapeutics, about pulmonary hypertension in interstitial lung disease (PH-ILD), a serious and often under-recognized condition at the intersection of two progressive diseases. We discuss the importance of early recognition, the role of multidisciplinary care, emerging treatment options, and what patients, clinicians, and payers should know to improve outcomes. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you'll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care.  Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime's research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions. Research topics covered:Three-Year Real-World Adherence and Persistence to Glucagon-Like Peptide-1 Receptor Agonists Among Commercially Insured Adults with Obesity without Diabetes Trends in Real-World Persistence to Weight Loss Glucagon-Like Peptide-1 Receptor Agonists from 2021 to 2024 Among Commercially Insured Adults without Diabetes — This study earned a platinum award from AMCP.  Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program— This study earned a gold award from AMCP.Validation of Long-term Savings from a Pharmacist-to-Prescriber Telephonic Intervention — This study earned a gold award from AMCP. Total Cost of Care and Adverse Effects Assessment of Bispecific T-cell Engagers and Chimeric Antigen Receptor T-cell Therapies for Relapsed Refractory Follicular Lymphoma  -------------------------Content in this podcast is for informational or educational purposes only.The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

On this episode, host Fred Goldstein invites Arash Mostaghimi, MD, MPA, MPH, Vice Chair of Clinical Trials and Innovation, Brigham & Women's Hospital Department of Dermatology. Dr. Mostaghimi to discuss alopecia areata—an autoimmune disease that causes patchy or complete hair loss—its inflammatory basis, how severity is measured, and the profound psychosocial impacts on patients and families. They also review the latest FDA-approved therapies, evolving treatment guidelines, and what patients, clinicians, and payers should know as new options reshape care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this milestone episode of Unscripted, the AMCP Podcast, they celebrate the 30th anniversary of the Journal of Managed Care & Specialty Pharmacy (JMCP). Host Susan Cantrell, AMCP CEO, is joined by Laura Happe, PharmD, MPH, Editor-in-Chief of JMCP, and Pat Gleason, PharmD, BCPS, FCCP, FAMCP, Assistant Vice President, Health Outcomes at Prime Therapeutics to reflect on the journal's evolution from its 1995 launch to today's leading voice in managed care pharmacy. Highlights include JMCP's role in shaping policy, advancing research, and tackling pressing issues such as drug pricing, equity, and access—while looking ahead to the future of pharmacy innovation and collaboration. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode host Fred Goldstein invites Aaron Crittenden, President of Rx Marketplace at GoodRx, to discuss Community Link, a new program from GoodRx that empowers independent pharmacies through direct contracting, predictable pricing, and access to over 90 brand medication deals. Aaron explains how Community Link helps pharmacies stay competitive, provide affordable prescriptions for patients, and build more sustainable economics in today's challenging marketplace. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On this episode host Fred Goldstein invites Dr. Harrison Nguyen, a double board-certified dermatologist and health economist, about the true scope of psoriasis. From overlooked symptoms and high-impact areas to the systemic nature of the disease, Dr. Nguyen explains why a personalized treatment strategy is essential. He also explores the economic case for early intervention and access to advanced therapies. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On this episode host Fred Goldstein invites Tonja Johnson, founder of the Beautifully Unblemished Vitiligo Support Group. Tonja shares her personal journey with Vitiligo, from diagnosis and frustration to advocacy and empowerment. In recognition of World Vitiligo Day, this conversation explores the physical, emotional, and social challenges of living with the condition, the ongoing stigma and mental health impact, and the urgent need for health plans to treat Vitiligo as more than cosmetic. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On this episode host Fred Goldstein invites Joe Honcz, from C4I consulting and an AMCP Board Member to discuss AI and its potential uses in Managed Care Pharmacy. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

IBD 3 Part Series On this Part 3 of 3 episode host Fred Goldstein invites Dr. Christine Frissora, gastroenterologist and associate professor of clinical medicine, at The NY Presbyterian Cornell University Medical Center and Dr. Ken Schaecher, chief medical officer emeritus, University of Utah Health Plans and chief medical officer at a regional health plan and practicing general internal medicine specialist. On this episode the doctors share a study on the costs savings associated with using the VibrantGastro system and information for payers. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

This episode of the Astonishing Healthcare podcast highlights two recent posters presented by Zachary Brunko, PharmD (PGY1 Managed Care Pharmacy Resident), and Nash Albadarin, PharmD, MBA (Associate Director, Clinical Programs Business Development), at AMCP 2025 and the 2025 PQA Annual Meeting, respectively. We won't give away the conclusions, but Zach explains the team's research on International Classification of Diseases (ICD) codes and how they evaluated the accuracy and reliability of ICD codes submitted on pharmacy claims. Additionally, they sought to identify patterns in ICD code submissions across client types, drug classes, disease states, pharmacy networks, and regions.Nash highlights how text messaging and pharmacist outreach to patients through Rx Enhance - a clinical program designed to improve adherence and close gaps in care - drove marked improvement in medication adherence in 2024 for commercial plan members with diabetes, hypertension, and high cholesterol. If you're interested in the potential to streamline processes and improve decision-making by using data like ICD codes, or the potential for tech-enabled clinical programs to improve health outcomes, this episode is for you!Reference Materials & Related ContentPoster: Evaluating ICD Codes on Pharmacy Claim Submissions: Are They Reliable?Poster: The Impact of Text Messaging and Pharmacist Outreach Interventions on Medication Adherence Rates in a Commercial PBM PopulationAH043 - Pharmacy Benefits 101: DMP & MTM, Explained, with Nash Albadarin, PharmDAH035 - Pharmacy Benefits 101: Clinical Programs, with Bonnie Hui-Callahan, PharmDAH006 - Pharmacy Benefits 101: Clinical Care Teams, with Amy Stockton, PharmDPlease visit Capital Rx Insights for more information, including this episode's transcript!

IBD 3 Part Series On this Part 2 of 3 episode host Fred Goldstein invites Dr. Christine Frissora, gastroenterologist and associate professor of clinical medicine, at The NY Presbyterian Cornell University Medical Center and Dr. Ken Schaecher, chief medical officer emeritus, University of Utah Health Plans and chief medical officer at a regional health plan and practicing general internal medicine specialist. On this episode the doctors share information on the costs associated with treating IBD, as well as introduce the Vibrant System and some of its advantages. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Have you ever wondered what your pet is really thinking behind those adorable eyes? What if grooming your pet was more than a task, but a sacred exchange of trust and care? In this week's episode, Aimee sits down with Cassondra Smith, CEO of Club Pawsh and host of The Unlimited Groomer podcast. Cassondra shares her inspiring journey from music industry professional to animal wellness educator, speaker, and grooming expert. Whether you're a pet parent, an animal professional, or simply someone who believes in care-centered living, this conversation will expand your heart and perspective.In this episode, you'll hear:- Cassondra's journey from cubicles to canines, and finding her true calling- How grooming is about more than looks, it's about trust, healing & communication- The concept of Fear Free grooming and why it's changing the industry- Why understanding animal behavior matters more than ever- How somatic awareness applies to animals and what they teach us about energy- The emotional impact of trauma (for pets and humans) and how to rebuild the connectionAnd so much more!Cassondra Renee FFCP-G, AMCP, founder and CEO of Club Pawsh, is described as the only All-Luxury & Fear Free Certified Mobile Groomer in Buffalo, New York. She is a seasoned groomer with over 10 years of experience in in-home, mobile, and salon settings. Cassondra has also held corporate roles overseeing hundreds of groomers, where she developed a passion for coaching and advising others in the industry to achieve success financially and personally. Her background includes personal development, a collegiate background in psychology, and a Bachelor's of Science in Music Business Management.Cassondra's expertise and empowerment coaching have been featured in various media outlets, including Reader's Digest, television news, and animal sanctuary organizations. She also educates on platforms and podcasts within the grooming industry. Alongside her podcast, "The Unlimited Groomer," she offers business coaching tailored to pet industry professionals and is available for speaking engagements. Additionally, she runs Pawscious Memories, which creates handmade pet keepsakes incorporating hair and cremains. Outside of her professional life, Cassondra has five pets, is involved in WINC (an organization supporting women in business), practices yoga and meditation, and enjoys dancing, reading, roller skating, and traveling.Connect with Cassondra:Socials: @clubpawsh, @unlimitedgroomer Website: clubpawsh.com Connect with Aimee:Instagram: @aimeetakaya Facebook: Aimee Takaya Learn more about Aimee Takaya, Hanna Somatic Education, and The Radiance Program at⁠⁠ ⁠⁠⁠www.freeyoursoma.com⁠⁠⁠.⁠⁠

IBD 3 Part Series On this Part 1 of 3 episode, host Fred Goldstein invites Dr. Christine Frissora, gastroenterologist and associate professor of clinical medicine, at The NY Presbyterian Cornell University Medical Center and Dr. Ken Schaecher, chief medical officer emeritus, University of Utah Health Plans and chief medical officer at a regional health plan and practicing general internal medicine specialist. Dr. Frissora shares her insights on a new, non-pharmacological treatment for Chronic Idiopathic Constipation. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

And here we are, at the Academy of Managed Care Pharmacy Annual for a 2nd year in row for a special “on the road” episode of Pharmacy Friends.  This year, AMCP is in Houston with more than 6,000 managed care pharmacy and health care industry professionals in attendance. And thought leaders from Prime Therapeutics are also on hand to present 7 research posters and several education sessions based on our integrated medical and pharmacy claims data. This episode will help you gain clarity on the real-world impact of GLP-1 drugs, understand how predictive modeling can help identify members enrolled in Medicare Part D at risk of large increases in prescription drug spending, and other trends shaping the health care industry.We also have two up and coming researchers share their experience taking their first steps in the managed care space and their careers. (00:00) Introduction(01:05) 2024 JMCP “Article of the Year” Award for Excellence(06:46) Latest GLP-1 research(15:56) Accelerated Drug Approval Program (28:00) PBM and Medical Pharmacy Industry Trends(41:17) Medicare Member Drug Cost Predictive Model: Creation and Feature Engineering (50:32) Advancing Health Equity in Food Allergy Prevention and Treatment: Bridging Gaps in Care and Knowledge(55:22) Legislative Impacts on Site of Service: What is the Big Deal?(1:00:07) The next generation of managed care professionals

E32: IBD Innovations, Challenges, and the Future of Care On this episode host Fred Goldstein invites Casey Koch, PharmD, Clinical Pharmacy Coordinator at Select Health. We explore the discuss the evolving landscape of inflammatory bowel disease (IBD), including the latest treatment advancements, guideline updates, and the role of managed care pharmacy in optimizing patient outcomes. From biologics to biosimilars, personalized medicine, and health disparities, we dive deep into the complexities of IBD management and what the future holds for patients and providers alike. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

E31: Health Policy and Regulations with the New Trump Administration On this episode host Fred Goldstein invites Andrew McKechnie from the Tiber Creek Group, Adam Colborn from AMCP, and Geni Tunstall from AMCP to discuss Health Policy under President Trump. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode host Fred Goldstein invites Elizabeth Powers, Vice President and General Manager, Regulatory Science and Study Innovation at IQVIA, to discuss Real World Evidence. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Host Fred Goldstein invites Brian Hilberdink, President, Executive Vice President North America and Douglas Maslin, MD, Global Principal Medical Advisor to discuss LEO Pharma and their involvement with AMCP. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On this episode host Fred Goldstein invites Adam Hoye-Simek, Senior Pharmacy Manager of Utilization Management at Devoted Health, to discuss the latest update to the AMCP Format for Formulary Submission, version 5.0. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode host Fred Goldstein invites Hilly Paige, Chief Innovation Officer at the Family Heart Foundation. Hilly discusses the work of the Family Heart Foundation. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Host Fred Goldstein invites David L. Kamelhar, Clinical Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine at the NYU Grossman School of Medicine, and Dr. Sunjay Devarajan Assistant Professor of Internal Medicine, Pulmonary/Critical Care at the Baylor College of Medicine to discuss the latest in the treatment of Bronchiectasis. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this special episode offering CPE Credits, Fred Goldstein Invites Susan Wojcicki Roman, clinical pharmacy lead at Humana Pharmacy Solutions to discuss Breaking Biases in Breast Cancer. This activity is supported by an independent medical education grant from Novartis Pharmaceuticals Corporation and Merck Sharp and Dohme. AMCP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Full instructions on how to claim CPE credits can be found here (https://acrobat.adobe.com/id/urn:aaid:sc:VA6C2:cce0dc42-2b1b-4e42-8543-d1c93730e81d) Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this special episode offering CPE Credits, Fred Goldstein Invites Danielle Roman, manager of clinical pharmacy services at Allegheny Health Network Cancer Institute to discuss Breast Cancer Breakthroughs: A Peek into the Pipeline. This activity is supported by an independent medical education grant from Novartis Pharmaceuticals Corporation and Merck Sharp and Dohme. AMCP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Full instructions on how to claim CPE credits can be found here (https://acrobat.adobe.com/id/urn:aaid:sc:VA6C2:cce0dc42-2b1b-4e42-8543-d1c93730e81d) Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

On this episode host Fred Goldstein Invites Erica Klinger, VP of Marketing at AMCP. Erica Discusses AMCPs Markeing efforts including the We are MCPs initiative. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Host Fred Goldstein Invites Sarah Edmonds, President and CEO of ICER to discuss ICERs, Health Technology Assessments and determing value as we seek to move to a value based healthcare system. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Host Fred Goldstein invites Ruchi Gupta, MD professor of pediatrics and medicine at Northwestern University Feinberg School of Medicine, and the founding director of the Center for Food Allergy and Asthma Research to discuss Food Allergies, their prevalence, new treatments and how payers should look at this area.

On this episode host Fred Goldstein invites Geni Tunstall, Director, Regulatory Affairs at AMCP to discuss the Inflation Reduction Act or IRA and its many pharmacy related topics including the Medicare Drug Price Negotiations. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Host Fred Goldstein invites Jennifer Mathieu, Senior Vice President, Professional & Government Affairs to discuss the Prescription Digital Therapeutics Act, the Medicaid MVPs for Patient Act and other AMCP legislative priorities. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/